Skip to main content
Loading...
Menu top
Help
User account menu
Log in
Main navigation
Programme
Posters
Industry Symposia
Membership
Mobile Application
Menu
Login
Close
Main navigation mobile
Programme
Posters
Industry Symposia
Membership
Mobile Application
Back
7 résultats
Grid
List
Oral microbiome’s impact on mucositis and locoregional tumor control in HNSCC patients undergoing radiotherapy
Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.
Pembrolizumab plus platinum and taxanes as first-line and as neoadjuvant/induction therapies in PF-unfit patients with PDL1-positive squamous cell carcinoma of the head and neck
Real world data on Low-Dose Nivolumab with Triple Metronomic Chemotherapy: Retrospective analysis of 50 consecutive patients from LMICs
Efficacy of nivolumab versus pembrolizumab in rmHNSCC. A prospective national multicenter study.
Efficacy and Safety of Salvage Chemotherapy After Progression to Anti-PD(L)1 Agents in Patients with Recurrent/Metastatic Head and Neck Cancer
EFFICACY AND SAFETY OF CHEMO-IMMUNOTHERAPY IN RECURRENT/METASTATIC HNSCC: A RETROSPECTIVE ANALYSIS
